Brought to you by 
Another late-stage round brings $51.2mm to TransMedics; $12.5mm added
25 Jul 2016
Executive Summary
TransMedics Inc. raised $51.2mm through a late-stage funding round (likely its Series I) from co-lead investors Fayerweather Fund, Pharmstandard International (represented by InBio Ventures), Ervington Investments, and BioStar Ventures. Existing investors Abrams Capital, Lung Biotechnology PBC, Flagship Ventures, and Kleiner Perkins Caufield & Byers also participated. TransMedics markets the Organ Care System, the first ever portable warm blood perfusion system for living organ transplants.
Deal Industry
- Medical Devices
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Another late-stage round brings $51.2mm to TransMedics; $12.5mm added
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice